Plasma angiotensin Ii levels in African hypertensives
Leary, W.P.; Asmal, A.C.
African Journal of Medicine and Medical Sciences 5(2): 165-167
1976
ISSN/ISBN: 0309-3913 PMID: 829723 Document Number: 108389
Plasma angiotesin II levels were measured by immunoassay in twenty-seven Zulus with raised arterial pressures. Angiotensin levels were higher in patients with malignant than benign essential hypertension, mean values being 260.2 and 90.7 mumicrogram/ml with stanard deviations of 119.4 and 25.1 respectively (P = less than 0.0005).
Document emailed within 1 workday
Related Documents
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941Hammer, M.; Olgaard, K.; Madsen, S. 1980: The inability of angiotensin II infusions to raise plasma vasopressin levels in haemodialysis patients Acta Endocrinologica 95(3): 422-426
Sharma, P. 1997: Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives Circulation 95(1): 281-284
Aoyama, K.; Ogata, M.; Sata, T.; Shigematsu, A. 1992: Plasma levels of alpha-human atrial natriuretic peptide, renin activity and angiotensin Ii in partial hepatectomy MASUI. Japanese Journal of Anesthesiology 41(1): 37-42
Musumeci, V.; Baroni, S.; Cardillo, C.; Zappacosta, B.; Zuppi, C.; Tutinelli, F.; Folli, G. 1987: Cardiovascular reactivity, plasma markers of endothelial and platelet activity and plasma renin activity after mental stress in normals and hypertensives Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 5(5): S1-S4
Spieker, C.; Zidek, W.; Vetter, H.; Rahn, K.H. 1991: Ambulatory 24-h blood pressure monitoring in essential hypertensives treated with the angiotensin-converting enzyme inhibitor ramipril Journal of International Medical Research 19(1): 39-43
Onyesom, I.; Inmuere, F.; Awhin, P.E. 2011: Levels of some micronutrients in some Nigerian hypertensives East African Journal of Public Health 8(3): 212-215
Küppers, H.; Wiesen, K.; Schnurr, E.; Grabensee, B. 1976: Determination of angiotensin Ii in plasma. Studies on the renin-angiotensin-aldosterone system Die Medizinische Welt 27(47): 2286-2288
Novo, S.; Adamo, L.; Giamporcaro, A.; Forte, G.; Longo, B.; Gallo, V.B.; Licata, G.; Strano, A. 1987: Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs) Agents and Actions. Supplements 22: 339-347
Kirkland, R.T.; Keenan, B.S.; Probstfield, J.L.; Patsch, W.; Lin, T.L.; Clayton, G.W.; Insull, W. 1987: Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels JAMA 257(4): 502-507
Vallotton, M.B. 1971: Parallel radioimmunoassays of angiotensin i and of angiotensin Ii for measurement of renin activity and of circulating active hormone in human plasma Hormone and Metabolic Research 3(Suppl 3): 94-100
Kooman, J.P.; Schalkwijk, C.G.; Konings, C.J. 2006: The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1 Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 410-411
Le Quan-Sang, K.H.; Levenson, J.; Simon, A.; Meyer, P.; Devynck, M.A. 1987: Platelet cytosolic free Ca2+ concentration and plasma cholesterol in untreated hypertensives Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 5(5): S251-S254
Verho, M.; Bossaller, W.; Malerczyk, V. 1988: Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride International Journal of Clinical Pharmacology Research 8(1): 5-8
Robaczyk, M.G. 2002: Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol Annales Academiae Medicae Stetinensis 48: 283-300
Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Van Houten, H.; Gooszen, H.G.; van den Akker, P.J.; Lemkes, H.H.; Frölich, M.; van Gurp, M.; van der Woude, F.J.; Rischen-Vos, J.; Terpstra, J.L. 1990: Plasma insulin, C-peptide, HBA1c, and plasma glucose levels in organ donors Transplantation Proceedings 22(2): 435-436
Bocci, V.; Carraro, F.; Naldini, A.; Borrelli, E.; Biagi, G.; Gotti, G.; Giomarelli, P.P. 1990: Interferon levels in human pulmonary tumors are lower than plasma levels Journal of Biological Regulators and Homeostatic Agents 4(4): 153-156
Mason, M.; Rivers, J. 1970: Factors influencing plasma ascorbic acid levels of pregnant women. I. Predicting second and third trimester levels Journal of the American Dietetic Association 56(4): 313-320
Annunziato, L.; Di Renzo, G.F.; Schettini, G.; Scapagnini, U.; Preziosi, P. 1977: Increased plasma corticosterone and decreased plasma thyroid-stimulating hormone levels in rats treated with vincristine Cancer Research 37(8 Part 1): 2574-2577